Found 12 matching trials
Switching From Xiidra to TRYPTYR PHASE4 To determine the efficacy of switching participants who are being treated w...
Show More Location
Multiple Locations
Learn More & Join Trial
Moderate-to-Severe Dry Eye Disease Relief Using Acoltremon N/A To evaluate the impact of Acoltremon 0.003% on subjective dry eye symptoms ...
Show More Status
Enrolling By Invitation
Location
Colvard-Kandavel Eye Center
Learn More & Join Trial
TRYPTYR as a Treatment for Patients With Dry Eye Disease (DED) PHASE4 The purpose of this research study is to determine the effectiveness of TRY...
Show More Location
NYU Langone Health
Learn More & Join Trial
A Study to Evaluate 0.003% AR-15512 Safety and Drop Attributes PHASE3 The purpose of this study is to evaluate the percentage of ocular adverse e...
Show More Location
Eye Research Foundation
Learn More & Join Trial
Effect of Acoltremon Ophthalmic Solution 0.003% on Signs and Symptoms of Ocular Surface Disease in Stage I Neurotrophic Keratopathy Patients With Tear Deficiency PHASE4 STUDY OBJECTIVE To assess if acoltremon 0.003% improves tear production in ...
Show More Location
University of South Florida/Ophthalmology
Learn More & Join Trial
A Study to Investigate the Effect of 0.003% AR-15512 on Subjects With Dry Eye Disease PHASE3 The purpose of this study is to evaluate the effect of AR-15512 ophthalmic ...
Show More Location
Butchertown Clinical Trials
Learn More & Join Trial
A Study Designed to Evaluate Tear Production PHASE3 The purpose of this study is to evaluate tear production following acute ad...
Show More Location
Eye Research Foundation
Learn More & Join Trial
Switching From Restasis to TRYPTYR PHASE4 Switching to acoltremon 0.003% will significantly improve the signs and sym...
Show More Location
Multiple Locations
Learn More & Join Trial
Long-term Effects of Acoltremon vs. Control in Dry Eye Disease N/A This is a prospective, longitudinal, single-center study designed to evalua...
Show More Location
Butchertown Clinical Trials
Learn More & Join Trial
Investigator Initiated Trial Using Dry Eye Surveys to Evaluate and Better Understand FDA Approved Acoltremon Treatment for Dry Eye Disease in Real World Treatment Settings (DESERT) PHASE4 Dry eye disease (DED) is a common, chronic and multifactorial disease of th...
Show More Learn More & Join Trial